GE HealthCare FLEXes its Profits Muscle with Staggering Imaging Device Demand

GE HealthCare exceeds quarterly profit projections driven by strong demand for imaging devices

GE HealthCare Technologies Inc Beats Wall Street Expectations, Surge in Medical Device Sales

Newsflash: GE HealthCare Technologies Inc (GEHC.O) has left Wall Street in awe with its third-quarter profit, exceeding expectations. It turns out that the demand for medical devices has skyrocketed, and GE HealthCare is reaping the benefits.

The rise in demand comes as a pleasant surprise, following the decline in COVID-19 infections. Customers, especially those of the golden years, are flocking back to hospitals for surgical procedures like hip and knee replacements. And let’s not forget the boon that healthcare staffing shortages have received. They are easing like a gentle breeze on a hot summer day.

But GE HealthCare isn’t the only one having a field day. Abbott Laboratories (ABT.N), a bigger player in the market, also topped its quarterly profit estimates. Everyone is enjoying the recovery in sales, especially in medical devices such as heart valves and pacemakers.

Being on cloud nine, GE HealthCare has even raised its annual adjusted profit forecast. They have pushed up the low end to $3.75 per share, while the top end retains its lofty position at $3.85.

In an unexpected twist of events, on October 16, U.S. health officials decided to lift restrictions on reimbursement for a non-invasive imaging test called amyloid PET. This test is used to diagnose Alzheimer’s, opening up access to PET scanners manufactured by companies like GE HealthCare. These scanners were previously confined to limited spaces like clinical trials. Now, everyone can join the PET party!

• Blackstone & Vista Equity A Dynamic Duo Coming to the Rescue of...
• China Evergrande Fights to Avoid Liquidation, Can They Convince The...
• The Happiest Country in the World? This Finnish Company’s 10%...

And the good news doesn’t stop there. Last quarter, GE HealthCare hinted that Alzheimer’s-related testing would drive demand for its imaging equipment in hospitals and medical centers next year. Talk about planning ahead!

GE HealthCare has four wings of medical device businesses, each serving its own purpose. We have imaging equipment, ultrasound devices, patient care solutions, and pharmaceutical diagnostics. But the biggest wing, the superstar of the show, is undoubtedly imaging.

In terms of numbers, GE HealthCare reported total quarterly sales of a whopping $4.82 billion for the third quarter ending on September 30. Take that, analysts! They estimated $4.81 billion, but GE HealthCare said, “Hold my stethoscope!”

Now, let’s dig deeper into the numbers. Of the $4.82 billion, a staggering $2.64 billion came from imaging devices. That’s right, the machines that capture what’s happening inside our precious bodies. The estimated figure didn’t stand a chance.

Speaking of figures, on an adjusted basis, GE HealthCare earned 99 cents per share, which surpassed the estimates of 90 cents made by LSEG. It’s safe to say that GE HealthCare knows how to make those numbers dance to its tune.

So, dear readers, it seems GE HealthCare Technologies Inc is on cloud nine, flying high with their amazing profit performance. With the surge in demand for medical devices and a promising future, this company is radiating success. Who said numbers couldn’t be exciting?

Our Standards: The Thomson ANBLE Trust Principles.

• AER
• AERO
• AMED
• AMED1
• BACT
• BISV
• BISV08
• MTPIX
• RHPI:COMMERCIAL-STRATEGY
• RULES:RESULTS